Ann: First UK orders, expanding presence in the UK Market, page-37

I think in the excitement of this PCS deal, on the second page of the announcement, we could miss this new partnership:

PainChek UK has also teamed up a with an Outstanding Care Quality Commission (CQC) rated dementia focussed care home based near Manchester as part of our direct selling to aged care programme. The CQC rating is the highest rating a home can achieve as an aged care facility in the UK. They are excited to have adopted the PainChek technology as part of their overall offering, providing a clear endorsement to the market. The home has agreed to host other aged care visitors on a monthly basis to demonstrate the benefits the PainChek pain assessment tool brings to the adult social care market. This is part of the PainChek UK’s strategy to drive direct sales to the large number of UK aged care homes.

The UK market is being marketed from all angles. I believe the uptake in the UK market could well be much faster than Australia, subject to PCK's ability to implement them. I won't be surprised if they would need to expand the UK team shortly to cope with the demands in the UK and EU.

To be honest, this one announcement could well be divided into 3 announcements to drive sentiment. One is the PCS deal. The second is the Pete Shergill direct sale. And finally, this partnership with CQC. But nope, this is a company that is being run like a blue chip where announcements are released without funfare. It is up to us to read and comb through it and make sure we understand its full implication here.